AI assistant
HAEMONETICS CORP — Director's Dealing 2012
Jan 20, 2012
31565_dirs_2012-01-20_59d85fbf-6bc6-4c6b-8ad5-901bc2ff3dc4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2012-01-18
Reporting Person: LINDOP CHRISTOPHER J (CFO & VP, Business Dev.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-01-18 | Common Stock | D | 186 | $63.3808 | Disposed | 13618 | Direct |
| 2012-01-18 | Common Stock | D | 102 | $63.3808 | Disposed | 13516 | Direct |
Footnotes
F1: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.
F2: Subsequent to the original filing it was discovered that the original transaction did not occur on 10/23/11. This filing amends the date, shares, sale price, and securities beneficially owned based on the revised transaction date.
F3: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
F4: Subsequent to the original filing it was discovered that the original transaction did not occur on 10/24/11. This filing amends the date, shares, sale price, and securities beneficially owned based on the revised transaction date.